These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


568 related items for PubMed ID: 18166249

  • 21. Potentiation of an anthrax DNA vaccine with electroporation.
    Luxembourg A, Hannaman D, Nolan E, Ellefsen B, Nakamura G, Chau L, Tellez O, Little S, Bernard R.
    Vaccine; 2008 Sep 19; 26(40):5216-22. PubMed ID: 18462850
    [Abstract] [Full Text] [Related]

  • 22. Topical immunization onto mouse skin using a microemulsion incorporated with an anthrax protective antigen protein-encoding plasmid.
    Cui Z, Sloat BR.
    Int J Pharm; 2006 Jul 24; 317(2):187-91. PubMed ID: 16730934
    [Abstract] [Full Text] [Related]

  • 23. A synthetic peptide vaccine directed against the 2ß2-2ß3 loop of domain 2 of protective antigen protects rabbits from inhalation anthrax.
    Oscherwitz J, Yu F, Cease KB.
    J Immunol; 2010 Sep 15; 185(6):3661-8. PubMed ID: 20696862
    [Abstract] [Full Text] [Related]

  • 24. Protection against anthrax and plague by a combined vaccine in mice and rabbits.
    Ren J, Dong D, Zhang J, Zhang J, Liu S, Li B, Fu L, Xu J, Yu C, Hou L, Li J, Chen W.
    Vaccine; 2009 Dec 09; 27(52):7436-41. PubMed ID: 19635609
    [Abstract] [Full Text] [Related]

  • 25. Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin components.
    Mendelson I, Gat O, Aloni-Grinstein R, Altboum Z, Inbar I, Kronman C, Bar-Haim E, Cohen S, Velan B, Shafferman A.
    Vaccine; 2005 Dec 01; 23(48-49):5688-97. PubMed ID: 16039760
    [Abstract] [Full Text] [Related]

  • 26. S-layer homology motif is an immunogen and confers protection to mouse model against anthrax.
    Kulshreshtha P, Aggarwal S, Jaiswal H, Bhatnagar R.
    Mol Immunol; 2012 Feb 01; 50(1-2):18-25. PubMed ID: 22178119
    [Abstract] [Full Text] [Related]

  • 27. Identification and characterization of immunodominant B-cell epitope of the C-terminus of protective antigen of Bacillus anthracis.
    Kaur M, Chug H, Singh H, Chandra S, Mishra M, Sharma M, Bhatnagar R.
    Mol Immunol; 2009 Jun 01; 46(10):2107-15. PubMed ID: 19356802
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Protective activity and immunogenicity of two recombinant anthrax vaccines for veterinary use.
    Fasanella A, Tonello F, Garofolo G, Muraro L, Carattoli A, Adone R, Montecucco C.
    Vaccine; 2008 Oct 23; 26(45):5684-8. PubMed ID: 18775462
    [Abstract] [Full Text] [Related]

  • 31. A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores.
    Hermanson G, Whitlow V, Parker S, Tonsky K, Rusalov D, Ferrari M, Lalor P, Komai M, Mere R, Bell M, Brenneman K, Mateczun A, Evans T, Kaslow D, Galloway D, Hobart P.
    Proc Natl Acad Sci U S A; 2004 Sep 14; 101(37):13601-6. PubMed ID: 15342913
    [Abstract] [Full Text] [Related]

  • 32. Natural exposure to cutaneous anthrax gives long-lasting T cell immunity encompassing infection-specific epitopes.
    Ingram RJ, Metan G, Maillere B, Doganay M, Ozkul Y, Kim LU, Baillie L, Dyson H, Williamson ED, Chu KK, Ascough S, Moore S, Huwar TB, Robinson JH, Sriskandan S, Altmann DM.
    J Immunol; 2010 Apr 01; 184(7):3814-21. PubMed ID: 20208010
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Generation of a novel chimeric PALFn antigen of Bacillus anthracis and its immunological characterization in mouse model.
    Suryanarayana N, Verma M, Thavachelvam K, Saxena N, Mankere B, Tuteja U, Hmuaka V.
    Appl Microbiol Biotechnol; 2016 Oct 01; 100(19):8439-51. PubMed ID: 27364624
    [Abstract] [Full Text] [Related]

  • 35. A recombinant 63-kDa form of Bacillus anthracis protective antigen produced in the yeast Saccharomyces cerevisiae provides protection in rabbit and primate inhalational challenge models of anthrax infection.
    Hepler RW, Kelly R, McNeely TB, Fan H, Losada MC, George HA, Woods A, Cope LD, Bansal A, Cook JC, Zang G, Cohen SL, Wei X, Keller PM, Leffel E, Joyce JG, Pitt L, Schultz LD, Jansen KU, Kurtz M.
    Vaccine; 2006 Mar 06; 24(10):1501-14. PubMed ID: 16271808
    [Abstract] [Full Text] [Related]

  • 36. A novel live attenuated anthrax spore vaccine based on an acapsular Bacillus anthracis Sterne strain with mutations in the htrA, lef and cya genes.
    Chitlaru T, Israeli M, Rotem S, Elia U, Bar-Haim E, Ehrlich S, Cohen O, Shafferman A.
    Vaccine; 2017 Oct 20; 35(44):6030-6040. PubMed ID: 28342664
    [Abstract] [Full Text] [Related]

  • 37. BA3338, a surface layer homology domain possessing protein augments immune response and protection efficacy of protective antigen against Bacillus anthracis in mouse model.
    Kumar M, Puranik N, Varshney A, Tripathi N, Pal V, Goel AK.
    J Appl Microbiol; 2020 Aug 20; 129(2):443-452. PubMed ID: 32118336
    [Abstract] [Full Text] [Related]

  • 38. Increased long-term immunity to Bacillus anthracis protective antigen in mice immunized with a CIA06B-adjuvanted anthrax vaccine.
    Wui SR, Han JE, Kim YH, Rhie GE, Lee NG.
    Arch Pharm Res; 2013 Apr 20; 36(4):464-71. PubMed ID: 23440578
    [Abstract] [Full Text] [Related]

  • 39. Anthrax capsule vaccine protects against experimental infection.
    Chabot DJ, Scorpio A, Tobery SA, Little SF, Norris SL, Friedlander AM.
    Vaccine; 2004 Nov 15; 23(1):43-7. PubMed ID: 15519706
    [Abstract] [Full Text] [Related]

  • 40. Comparative vaccine efficacy of different isoforms of recombinant protective antigen against Bacillus anthracis spore challenge in rabbits.
    Ribot WJ, Powell BS, Ivins BE, Little SF, Johnson WM, Hoover TA, Norris SL, Adamovicz JJ, Friedlander AM, Andrews GP.
    Vaccine; 2006 Apr 24; 24(17):3469-76. PubMed ID: 16519970
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 29.